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Abstract 
Tuberculosis remains a threat to global health and recent attempts to shorten therapy 
have not succeeded mainly due to cases of clinical relapse.  This has focussed attention 
on the importance of “dormancy” in tuberculosis.  There are a number of different 
definitions of the term and a similar multiplicity of different in vitro and in vivo models. 
The danger with this is the implicit assumption of equivalence between the terms and 
models, which will make even more difficult to unravel this complex conundrum. In this 
review we summarise the main models and definitions and their impact on 
susceptibility of Mycobacterium tuberculosis.  We also suggest a potential nomenclature 
for debate.  Dormancy researchers agree that factors underpinning this phenomenon 
are complex and nuanced.  If we are to make progress we must agree the terms to be 
used and be consistent in using them.  
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Introduction 
Improvement in tuberculosis treatment is seen widely as an important goal of research 
to reduce preventable deaths.  One of the major barriers to progress is the prolonged 
duration of treatment, which has put an emphasis on the unusual nature of tuberculosis 
where the organism forms a life-long relationship with the host persisting in a low 
metabolic state in the tissues.  Recent phase III clinical trials of shortened regimens have 
failed to show non-inferiority mainly due to higher relapse rates in the experimental 
arms despite more rapid clearance of bacteria[1-3]. This implies that hidden 
populations of bacteria may be important in defining outcome as has been implied by 
recent publications [4,5].  Unravelling the biology of the relationship between dormancy 
and response to antibiotics are critical for the development of better treatments for 
tuberculosis. 
The diversity of terms used to describe the physiology of M .tuberculosis and other 
mycobacterial cells in tissues creates a communication challenge.  This has the effect 
that bacteriologists, immunologists, clinical trialists, clinicians and diagnosticians, are 
surrounded by a cloud of uncertain meaning.  That the same words have different 
meanings to scientists blocks progress in this already difficult area.  To address this 
issue we have reviewed and summarised the literature surrounding the term dormancy 
and its companion terms persistence and latency, whilst identifying some of the key 
biological questions that need to be addressed. We believe that it is only by creating a 
common language to underpin the scientific conversation that efficient progress in 
scientific knowledge is possible and will allow a future consensus to emerge and this is 
what we attempt to do in this manuscript.    
Dormant 
It is important to distinguish the terms dormant and dormancy from others that are 
often erroneously used as synonyms: latent/latency and persistent and persistence (see 
below).   A state of dormancy has been hypothesised for M.tuberculosis cells in human 
infection and it is a feature that has been recognised in a wide range of bacteria since 
1944 [6].  At its simplest, the term dormant might be defined as “having normal physical 
functions suspended or slowed down for a period of time; in or as if in a deep sleep”, but 
how can this anthropomorphic concept be applied to bacteria in humans?  The working 
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definition of mycobacterial dormancy is complicated by the fact that it is usually 
described negatively: inability to grow on solid medium, the presence of low metabolic 
activity, alteration of gene regulation with the accumulation of tri-acylglycerides in 
intracellular lipid bodies, loss of acid fastness, tolerance to antibiotics, and the 
imputation that growth rate is slow.  To explore this state a number of dormancy models 
have been developed and these are described in more detail in Table 1 and in the text 
below.  The critical, implicit and as yet untested assumption is that they all result in a 
similar phenotype and that these phenotypes are predictive of a state found in the 
human host. Although there have been many descriptions of the histopathological 
changes found in human and animal models of disease none of these unequivocally 
identify mycobacterial cells in a dormant state[7,8]. 
Experimental data are starting to reveal the physiological state of organisms that might 
be candidates to be the elusive dormant cell, for example some organisms in human and 
animal specimens cannot be recovered on solid medium and can only be detected by 
growth in liquid culture broth or by the addition of resuscitation promotion factor 
(Rpf)[9-11].  Studies have shown that, after a course of chemotherapy, liquid culture and 
the tissues of mice contain un-culturable cells that transcribe messenger RNA[12]. Using 
a fluorescent marked reporter strain the lungs of chronically infected mice have been 
shown to harbor a subpopulation of non-growing but metabolically active bacteria.  
Such bacterial cells are notable in mice treated with the isoniazid, suggesting that they 
may have a role in post-chemotherapeutic relapses.[13] Reports also indicate that, as 
mycobacteria become increasingly difficult to resuscitate, they have less capacity to 
cause infection in mice[14].  
The physiological conditions within a patient with tuberculosis are starting to be 
understood and research has been directed towards extending this knowledge and 
finding models that recreate these conditions.  The caseous granuloma is thought to be 
an anaerobic environment providing circumstantial support for the importance of some 
in vitro models described in more detail below.  A “dormancy” phenotype can be created 
in the laboratory by applying different forms of stress: oxygen or nutrient deficiency, 
hyper-acidity, antibiotics and multiple combinations of these. The published models 
include bacterial starvation[15], successive shift-down or anaerobiasis (the Wayne 
model)[16], external acidification[17], antibiotic survival[12,18], multiple stress [19-21] 
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and these are reviewed in turn.  For the moment we will call all of these “dormancy” 
models, recognising that, at present, we only have an atlas of phenomenology and there 
is a need to identify the characteristics of each model comprehensively.   
 
Lipid body positive 
 Lipid bodies were first described in a range of bacteria among which was M.tuberculosis 
and other mycobacteria including M. leprae where it was classified as “fatty material 
usually present but sometimes absent in common media[22,23].   These enigmatic 
bodies were little studied until the work of Garton and colleagues who showed that lipid 
bodies could be formed rapidly from uptake of fatty acids or from simple carbon sources 
in low-nitrogen conditions[24]. The lipid bodies contain poly-β-hydroxyalkanoates, tri-
acylglycerides and wax esters[24].  Such lipid bodies are found more commonly as 
bacteria progress to stationary phase as illustrated in Figure 1. Lipid bodies are found 
more commonly in late stationary phase cultures of mycobacteria, which are known to 
be more resistant to drugs and the concentration of drug required to clear all bacteria 
(the MBC- minimum bactericidal concentration) rises significantly[25].  Older cells 
express lipid bodies [24,26,27] and it was assumed they are responsible for the 
phenotypic resistance found.   
 
Lipid body positive bacteria have been found to predominate in human sputum and this 
was associated with transcriptional signatures similar to those found in non-replicating 
mycobacteria[9] The authors found that the lipid body count was highly correlated with 
time to positivity in diagnostic liquid cultures, which they concluded established a direct 
link between this cytological feature and the size of a potential non-replicating 
population.   More recent work indicates that a range of growth-limiting stresses trigger 
a common signal transduction pathway slowing growth by redirecting carbon flux 
towards storage[7].  These data suggest that dormant bacteria survive chemotherapy 
both in vitro and in mice, and are metabolically active, although at a low level.   Other 
studies show that there is a difference between number of organisms cultivated on solid 
medium and detected by use of MGIT [28].  In a study of sequential sputum samples 
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from patients receiving standard chemotherapy between day 21 and 28 the change in 
the odds ratio of an unfavorable outcome for each percentage rise in percentage lipid 
body positive and the acid fast bacilli count was 1.21 (95% CI, .97–1.50; P = .088).   Thus 
it appears that patients with a greater percentage of lipid body positive mycobacterial 
cells detected in their sputum smear at later time points are more likely to have an 
unfavourable outcome[29].  The importance of lipid body positive bacteria has been 
emphasised by an in vitro study that demonstrates lipid body positive cells can be 
purified from all mycobacterial cultures tested and are phenotypically resistant to 
antibiotics irrespective of whether they are derived from “old” or “young” cultures 
indicating that the presence of a lipid body is associated with phenotypic antibiotic 
resistance[30].   
 
Hypoxia 
To create an in vitro hypoxic model Wayne and colleagues uses a long term culture 
without agitation and oxygen excluded[16].  They demonstrated a fourfold increase in 
the isoctrate lyase activity and ten-fold increase in glycine dehydogenase.  In a later 
variant of the model where anaerobiasis was achieved sequentially, relative resistance 
to isoniazid rifampicin and ciprofloxacin was demonstrated[16] accompanied by a loss 
of glycine dehydrogenase activity.   The Wayne model also includes an element of 
starvation (see below) through nutrient depletion[16].  The chaperonin alpha crystallin 
was found to be up-regulated in this model [31]and knockout of its gene led to an 
increased rate of growth in mice, suggesting that its function may be to slow growth in 
dormancy[32].  Many genes, including alpha crystallin alter their expression in response 
to hypoxia and are regulated by the DosR regulon.  This two component regulator alters 
the expression of a series of genes in response to hypoxia and nitric oxide[33] and redox 
stress[34]. A total of 50 genes are up-regulated including tri-acylglyceride 
synthase[19,21].  Comparing cells in a Wayne model with SWATH mass spectrometry it 
was shown that the DosR regulon induced proteins make up 20% of hypoxic cells 
compared with 1% in exponentially growing cells.  In comparison there was little 
change in ribosomal proteins.  Many components of the electron transport chain and the 
energy generating machinery changed in abundance.   Differential regulation of enzymes 
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in the sub-networks of acetyl-CoA alanine/ glutamate, and trehalose metabolism were 
found. Competing incorporation of acetyl-CoA either into TCA cycle or triacylglycerol 
biosynthesis was found consistently. Lipid pathways were significantly upregulated 
when absolute protein concentration and Vmax enzyme data were compared[35]. 
DosR is not an essential gene for survival in M.tuberculosis as knock out strains have 
only a modest decrease in viability in a hypoxic environment[36,37].  In a macaque 
model of infection, despite being able to replicate initially, animals infected with DosR 
regulon mutants failed to develop persistent infection or develop disease.  This was 
associated with the appearance of a Th1 response and organization of hypoxic lesions 
where M.tuberculosis expressed dosR[38].   Interestingly, some Beijing lineage strains 
have been shown to express DosR constitutively as well as accumulating large quantities 
of lipid in lipid bodies[19].  A recent study where the DosR regulon was induced to wild 
type levels did not change M.tuberculosis replication kinetics and the authors concluded 
that DosR expression alone is insufficient to explain latency[39].  A recent hypothesis 
published by Orme suggests that the triggering of the DosR is an adaptation to these 
inimical conditions created by necrosis of tissue by host generated radicals.  The 
necrotic centre created is hypoxic, but the dead neutrophils and other cells mean that 
the bacteria are not starved.  His argument is that the DosR response readies the 
organism for transmission: survival as an extracellular state[40].   
The importance of a hypoxia is supported by the accumulating evidence that anaerobic 
conditions are found in granulomas.  A hypoxia marker EF5 demonstrated granulomas 
with necrotic centres in human tissue, which contrasts with mouse granulomatous 
lesions where hypoxia does not appear to occur[41].     Significantly it has been shown 
that metronidazole has no effect on the outcome from the Cornell model of tuberculosis 
treatment (see below)[42] whereas this drug has been shown to be bactericidal with 
dormant mycobacteria[43].  The probe pimonidazole (PIMO), which binds to thiol-
containing peptides only at low partial pressures of oxygen, colocalised with areas of 
caseous necrosis in guinea pigs, rabbits, and cynomologous macaques [44], but not with 
cellular granulomas in the standard mouse model[46]. However, metronidazole lacked 
activity in a murine hypoxic granuloma model and in guinea pigs [47,48]. 
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In human lung tissue endothelial cells have been detected with an anti-CD31 
immunohistochemistry probe in granulomas with necrotic centres; thought to represent 
mature lesions.  These cells are not found in lesions without necrotic centres.  This 
observation may support the idea that hypoxia is associated with granuloma maturity 
[41].  The importance of the nature of the animal model is confirmed by a study study that  
compared the virulence of a strain of M. tuberculosis with a dosR-dosS deletion mutant 
(dosR-dosS [ dosR-S]), comparing it to complemented strain and wild-type H37Rv in 
rabbits, guinea pigs, and mice infected by the aerosol route as well as using a mouse hollow-fiber 
system.  In the mouse and the guinea pig models, the dosR-S mutant exhibited a growth 
defect but did not replicate more than the wild type[49].   In another guinea pig model, 
bedaquiline failed to eradicate bacteria in residual primary lesion necrosis with 
incomplete dystrophic calcification that is hypoxic and morphologically similar to that 
described in human lung lesions. This suggests that this acellular rim may be a primary 
hypoxic location populated by bacilli phenotypically resistant to this drug[50].     
These results contrast with those obtained when mycobacteria are exposed to a higher 
than atmospheric oxygen concentrations where there is increased multiplication by 
H37Ra and BCG strains[51].  
Starvation  
 Loebel first demonstrated that starved cells had minimal evidence of 
respiration[9,15,52].  Gegenbacher also used the Loebel model and showed that 
depletion of oxygen killed starved bacilli but death was prevented by nitrate indicating 
that survival and respiration was possible in the presence of an alternative exogenous 
electron acceptor. Nutrient-starved bacilli lacking isocitrate lyase failed to reduce their 
intracellular ATP level and died, thus establishing a link between ATP control and 
intermediary metabolism.  These data demonstrate a critical role for the glyoxylate 
shunt in survival in a nutrient limited environment[53].    
Betts et al developed this model further and demonstrated phenotypic resistance to 
rifampicin and isoniazid in starved cells that contrasted with full activity against 
exponentially growing cells.  Importantly, metronidazole had no effect on starved 
bacteria[54] as would be expected as its mode of action depends on reducing conditions 
adding to the importance of recognising that not all dormant phenotypes are identical.  
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Using this combined model they demonstrated differential up-regulation of proteins by 
micro-array[54,55].  They found evidence for slow- down of the transcription apparatus, 
energy metabolism, lipid biosynthesis and cell division in addition to induction of the 
stringent response and several other genes that may play a role in maintaining long- 
term survival within the host.  Energy metabolism genes (15%), 16% of lipid 
metabolism genes 59% of the translation apparatus were down-regulated. Of the 12 
M.tuberculosis sigma factors (sigB, sigE, sigF and sigD) four were up-regulated, but  sigA 
expression did not change significantly. The majority of differentially expressed cell 
process genes belonged to the transport/binding protein subclass[54].   
Another fermenter nutrient starvation model with controlled oxygen concentration,  
monitored nutrient depletion found up-regulation of genes in the glyoxylate shunt 
including isocitrate lyase, along with components of the TCA cycle. Sig B sig E and sigH 
were up-regulated and ATP synthase genes down-regulated.  In contrast to the results 
obtained by Betts et al., rpoA, B and rpoC was up-regulated.  All genes associated with 
the mas gene cluster were up-regulated throughout the period of stationary phase 
adaptation (mas, fadD26, fadD28, mmpL7, and ppsA-E) and at day 75 there was a sharp 
rise in expression of fadD26.  The enzyme Relmtb, which is required for survival of 
mycobacteria under long term in vitro starvation conditions was up-regulated by day 18 
and then declined slowly[56]. 
Xie varied the PBS starvation model and added 16 different agents to cultures 
suspended only in PBS and incubated these for 6 weeks.  Of these 16, only four 
(chlorpromazine, isoniazid, rifampin, trifluoperizine) where able to kill 99% of bacteria 
at concentrations less than 160mg/L[57].  There was one log difference in rifampicin 
susceptibility between log phase and starved cells and this increased to 2 orders for 
isoniazid.   
Nitrogen limitation 
Anuchin and colleagues developed a nitrogen limitation model in which M.tuberculosis 
cells adopted an ovoid morphology that were more resistant to heat, hygromycin and 
doxycycline stresses compared to a 48 hour culture[58].  In further studies, the authors 
found intra-species morphological heterogeneity of dormancy.  They defined cyst-like, 
coccoid and poorly differentiated cells that all showed dormant-like properties and yet 
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varied in their response to exogenous stress.  Cyst-like cells were shown to contain 
electron transparent lipid bodies and were most resistant to heat stress and displayed 
the greatest difference (two orders of magnitude) between viable count measured by 
colony forming units (cfu) and most probably number methods (MPN).   
 
Phosphate limitation 
It has been hypothesised that M. tuberculosis encounter a phosphate limited 
environment in the macrophage and that its response mediated through pkk1 and RelA 
are important for establishing tolerance to antibiotics[59,60].   
Acidification  
M.tuberculosis is sensitive  to low pH and survives in the phagolysosome by arresting 
acidification[61].  Pyrazinamide, a drug only active at low pH, can reduce treatment 
duration of tuberculosis chemotherapy from nine to six months, and it was postulated 
that this was due to its effect on cells in an acid environment [62].  When the pH was 
reduced, ovoid cells with thickened cell wall, a low metabolic activity and elevated 
resistance to antibiotics and heating developed and failed to form colonies on solid 
medium[17]. This phenomenon has been described in M.tuberculosis from sputum 
samples.[9].  Acidification was also used as part of a multiple stress model in 
M.tuberculosis  that included low oxygen (5%), high CO2 (10%), low nutrient (10% 
Dubos medium) [20,63].  The cells stopped replicating, lost their acid-fastness, and had 
reduced susceptibility to isoniazid and rifampicin whilst accumulating tri-acylglycerols 
and wax esters (WE) and up-regulating putative neutral lipid biosynthetic 
genes[18,20,64].f 
Multiple Stress 
Since M.tuberculosis faces a range of stresses it is logical that a more pathophysiological 
model would be one with multiple stresses.  Most models apply a single stress even 
though most impart additional unmeasured stresses on the culture (eg. accumulation of 
metabolites, gradual acidification, nutrient depletion).  Deb and colleagues created a 
‘multiple stress’  model:  low-nutrient (10% Dubos medium), acidic (pH 5.0), high CO2 
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(10%) and low O2 (5%)[20].  In these conditions the cells accumulated non-polar lipids 
as measured by TLC and [14C]oelic acid incorporation, were  resistant to isoniazid and 
rifampicin, lost acid fastness, increased Nile Red flouresence and decreased in buoyant 
density.  Genes involved in the glyoxylate cycle (icl, gltA1), carbon storage (tgs), stress 
response and hypoxia (hspX, Rv2031c, dosR) and anaerobic respiration (frdA, narG/H/X, 
nirA) were up-regulated.  Genes coding for expression of ATP and NAD energy 
regeneration systems and the transcription/translation apparatus were down-
regulated.  The authors believe that this provides a model where cells display all of the 
proposed hallmarks of dormancy.   
Stringent response 
The stringent response, which utilizes hyperphosphorylated guanine [(p)ppGpp] as a 
signalling molecule, controls gene expression during starvation and is under the control 
of the RelA and SpoT proteins in other species and by Rel(Mtb) in M. tuberculosis. This 
response has been shown to be critical to establish persistent infection in mouse and 
guinea pig models of tuberculosis and is associated with shut down of key metabolic 
pathways[65,66].  There is a link to differential antibiotic response as polyphosphate 
accumulation has been associated with tolerance to isoniazid in M. tuberculosis [67]. 
 
Resuscitation dependency 
Bacterial cells with phenotypic similarities with dormant bacilli as measured by the 
presence of lipid bodies have been detected in human sputum specimens[9,27] and can 
be the dominant cell type making  up to 99.9% of cells[12]. These cells may require the 
addition of a bacterial cytokine, resuscitation promotion factor (Rpf) to be detected by 
culture[9,68].  A study of smear-positive sputum samples from the UK and The Gambia 
revealed that up to 86% of those staining positively with Zhiel-Neelsen were also 
positive with Nile Red, a stain that preferentially binds lipid and showed these 
organisms had lipid bodies.  The transcriptome of these cells is similar to slowly 
replicating or non-replicating mycobacteria. Since the lipid body count was correlated 
with time to positivity in diagnostic liquid cultures the authors concluded that the 
presence of lipid bodies was linked to the size of the non-replicating population[27].  It 
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was notable that the characteristic of Rpf dependence was retained in long-term storage 
at 4°C.  There was a more rapid decline in the cfu count of non-Rpf dependent cells 
compared to the Rpf dependent count indicating that these latter cells are relatively 
resistant to rifampicin.  This resuscitation index continued to increase among a small 
number of subjects who were monitored over an extended period.  Direct treatment of 
sputum samples with rifampicin had less effect on Rpf cells supporting the idea that 
these cells were tolerant of this antibiotic at the low dose applied (1mg/L)[9].   
 
Antibiotic survival or persistence 
The term “persistence” is often used to describe bacteria surviving after a period of 
treatment.  The first description of rifampicin  tolerant cultures in which no bacteria 
could be cultured but messenger RNA of specific M.tuberculosis genes could be detected 
and radioactive uracil was incorporated, was performed by Hu and colleagues[11].   
These data suggest that dormant unculturable bacterial cells are metabolically 
active[69]. Further work led to the development of three separate models of antibiotic 
stress, namely 100 day microaerophilic cultures, pretreatment with rifampicin and the 
pulsed introduction of air[69-71]. These 100 day cultures contain 10-100 fold more 
unculturable cells which can be resuscitated with Rpf than culturable bacteria [11]. 
Clinical relapse was noted in the relapse of patients infected with resistant organisms in 
the first streptomycin trial[72] and it was McDermott who first suggested that the 
inability of drugs to kill all of the organisms was responsible for this phenomenon.  It 
was recognised early that the organisms were not eliminated by treatment in the mouse 
model but could not be identified by any method that required their multiplication 
although small numbers of acid fast bacilli could be seen[73].    Following cortisol 
therapy or spontaneously the infection relapsed and mycobacteria became detectable 
again.  It was in a subsequent paper that this group showed the importance of 
pyrazinamide in killing these “persisting” cells.  A characteristic that the authors 
described as  “sterilisation”[74].  These experiments were fundamental in developing 
what became known as the Cornell Model[75]. Further work with this model 
demonstrates that after the completion of chemotherapy, the tissues of the mice became 
“sterile”, no bacteria could be cultured from the tissues even in liquid cultures, yet 
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messenger RNA of specific M tuberculosis genes could be detected, suggesting that the 
bacteria, although dormant, were metabolically active[12].    The”sterile” phase of the 
Cornell model contains a high proportion of  Rpf-dependent M.tuberculosis cells which 
can be killed by high but not low dose rifampicin[11].   A second “persistence” model is 
described where a relatively resistant mouse strain C57/BL6 is inoculated by the 
aerosol or parenteral route.  The initial infection is controlled but the organism persists 
without causing overt disease[63].  
Keren and colleagues have selected for antibiotic persister cells by treating an 
exponentially growing culture with cycloserine and performing an Afymetrix array. 
They found that 1408 genes were down regulated and 282 up-regulated with growth 
and energy related genes extensively down regulated.  Of 65 Transcriptional activators 
listed in the  M.tuberculosis genome 10 were over-expressed in persisters. One of these, 
Rv2866, is a relE homologue and was recently shown to increase drug tolerance when 
over-expressed in an E. coli system.  Key genes up-regulated included sigF, dnaE2, acr2, 
lat and sig G.  They created a four-dimensional Venn diagram summarizing the 
differences and commonalities of four models: persisters, starvation, enduring hypoxic 
response (her), and non-replicating persistence. There are five genes that are common 
to all models and 55 genes that are common to persisters and at least 2 other models. Of 
special interest are the five genes that are overexpressed in all models. These genes are 
Rv0251c (acr2), encoding an alpha-crystallin, Rv1152, a transcriptional regulator of the 
gntR family, Rv2497c (pdhA), encoding a probable pyruvate dehydrogenase component, 
Rv2517c, encoding a hypothetical protein, and Rv3290c (lat), encoding an L-lysine-
epsilon-aminotransferase[18,64].     
Biofilm dormancy models 
Ackart and colleagues showed that M tuberculosis failed to form biofilms when cultured 
planktonically in the presence of Tween-80 and did not reach logarithmic phase growth 
and remained highly susceptible to antimicrobial drugs. In contrast when Tween is 
absent bacilli formed complex microbial communities attached to untreated well 
surfaces or to the extracellular matrix derived from lysed human leukocytes and 
tolerated drug treatment. This could be reversed by treatment of microbial communities 
with DNase I or Tween[76].  
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Implications of dormancy 
Susceptibility 
The importance of dormancy in M.tuberculosis is the repeated observation of phenotypic 
resistance to anti-tuberculosis agents although the degree is not fully delineated due to 
the different models of dormancy employed, the incomplete spectrum of agents tested 
and the diversity of susceptibility methods employed.  Cell wall inhibitors are most 
affected but the action of the RNA polymerase inhibitor rifampicin and fluoroquinolones 
acting on DNA gyrase is also reduced[16].  This is not to say that testing susceptibility of 
“dormant” cells is easy since, a priori, they may not grow well on standard solid media 
making methodology problematic.  In Table 2 we summarise the effect of different 
models on the susceptibility to antibiotics with the methods that were used.   
Through in vitro dormancy models a range of susceptibility test are used (MIC, MBC and 
percentage of cell surviving after different exposure time using CFU or resazurin 
reduction). This results in different drug dose for the same species through different 
models.  For example if we look at rifampicin in one species M.tuberculosis, in the Wayne 
model 0.1 µg/mL correspond to 4.2 % of bacilli surviving after 192 h of drug exposure 
and for the in vitro granuloma model a MIC was found between 0.47 and 0.94 µg/mL, 
illustrating the difficulties in comparing susceptibility results from different models 
even if they are generating “dormancy” cells types. To some extent these observations 
have been clarified by the report that indicates that it is the presence of a lipid body 
irrespective of cell age that is associated with a significant increase in the minimal 
bactericidal concentration of any mycobacterial species suggesting that this is a 
phenomenon common to the genus[30].    
 
Relationship to disease/pathology/treatment 
A number of narratives have been created to link the concept of dormancy with clinical 
disease and chemotherapy.  
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Special populations hypothesis  
The first “model” that attempted to this was the special populations hypothesis[62] 
based on clinical trial results with in vitro and mouse experiments.  It has four cell 
“types”: continuously growing cells, which isoniazid and rifampicin are said to act on, 
those in acid conditions, the target of pyrazinamide, intermittently metabolising cells 
against which rifampicin had its major activity and non-growing cells that are resistant 
to antibiotics[62].    This hypothesis has been influential in the design of clinical trials 
but there is limited direct bacterial or pathological evidence to support it .    
Yin-yang hypothesis  
Zhang and colleagues describe mixed growing and non-growing subpopulations that 
exist in a continuum of metabolic states. Among the growing sub-population (yang), are 
a small non- or slow -growing population (yin).  The evidence comes from batch culture 
growth curves and the authors describe that as bacteria enter stationary phase the yin 
increase and the yang decrease. This model, they postulate, explains why, after two 
months of treatment the persister cells revert to activity and can be killed by isoniazid 
and rifampicin and  why isoniazid is effective in the treatment of latent disease[77].    
This idea is supported by the observation that both lipid rich and lipid poor cells are 
found in cultures of all ages.   
The Scout hypothesis 
Shleeva and colleagues created a three stage model that described the change in status 
from active growth, through a transition stage to “deep dormancy”[78] n which  the cells 
were viable but not culturable.  The authors postulate that cells can reverse the journey 
and become active again and contrast the results from the Wayne model where cells 
retain the ability to be cultured with their own model where cells do not grow on solid 
medium without the addition of Rpf or culture supernatant[16]. This apparent 
discrepancy is resolved by the description of a “Wayne zone” that arises because of the 
shorter time to achieve the state. They also describe a “Cornell zone” in which cells enter 
a non-culturable state that precedes cell death.  These cells require external intervention 
before they can transition to the Wayne zone where resuscitation can occur if the 
correct conditions are encountered. Epstein built on this idea to postulate a dormant 
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state from which microbial cells awake at random.  The stochastic nature of this event 
could be precipitated by a change in a master regulatory gene.  These newly activated 
cells become scouts that, if they survive in the environment go on to form new colonies 
and through quorum sensing link to the larger bacterial population[79].  Disease 
recurrence would occur when scouts encounter a favourable environment before the 
bacterial population is eradicated by the immune system or chemotherapy. Although 
this appears to be an anthropomorphic explanation of events, it remains a stochastic 
process because “scouts” are continually produced and reactivation only occurs when 
one survives to multiply and cause relapse.   How dormancy might be linked with 
clinical models of latency is illustrated in the Figure 2. 
Disambiguation of dormancy 
Latency 
This term is an important concept in tuberculosis and the majority of those with 
primary infection are able to control the infection and may not show any clinical illness 
and some authors have suggested that latency and active disease are the extremes of a 
spectrum[80].  Epidemiological studies suggest that there is a 5-10% chance that the 
controlled, or latent infection will become patent to produce post primary disease.  This 
is thought to be the most frequent route to pulmonary tuberculosis[81].  Our ability to 
study and manage the latent form of disease has been transformed by enhanced 
diagnostic methods depending on tuberculosis specific T cell response assays or 
Interferon gamma response assays (IGRAs) that are superior to tuberculosis skin 
tests[82].   
The importance of latent infection in the natural history of tuberculosis has often led to 
a potentially false link with bacteriological considerations of dormancy.  The assumption 
is that the mycobacterial cells in latent infection are dormant.  Yet, there is little 
experimental evidence to support this hypothesis.   Patients with latent infection can be 
treated successfully with isoniazid, a drug that inhibits cell wall synthesis.  The 
observations of Rpf dependent cells that show reduced metabolic activity go some way 
to creating a bridge between the concepts of dormancy and latency[9,27]. PCR has 
detected M.tuberculosis  in sections of adipose tissue samples from 39 subjects from 
Mexico and France who had died from causes other than TB. M.tuberculosis DNA could 
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be detected fat tissue surrounding the kidneys, the stomach, the lymph nodes, the heart 
and the skin in 9/57 Mexican samples (6/19 individuals), and in 8/26 French samples 
(6/20 individuals)[83]. Other post mortem studies reported similar results[84]. A 
subsequent study identified viable bacilli in extrapulmonary sites, as evidenced by the detection 
of mycobacterial mRNA.[85].   Further work is required using RNA based methods to 
confirm that activity level of bacterial cells in tissue.   To avoid misunderstanding the 
authors believe the term latency should only be used in relation to a clinical disease 
state and dormancy to the bacterial cell state.  
 
A new nomenclature 
Using the data set out in this review we propose that the term dormancy should only 
apply to bacterial cells and specifically those that are capable of regrowth: it should be a 
reversible phenomenon.  Bacteria in a viable non-culturable state, for example, would 
have to be capable of resuscitation to qualify as “dormant” and to distinguish them from 
“dead”.  
 Given the multiplicity and complexity of models described we propose here that a 
dormancy model should be sub-defined by additional terms. Thus, the Loebel model 
would be described as dormancy-starvation.   Examples of how this approach could be 
notated are found in Text box 2 and applying this could do much to create clarity in this 
important area of mycobacterial research 
Future challenges and research 
In this review we have described the range of models of “dormancy”, yet, there are only 
a few reports of such cells from patient samples[9,27].  Further study of patient material 
is needed to understand the role of different dormancy phenotypes in human disease.  
This would test the relationship between in vitro and animal models and clinical disease.  
Descriptions of the cell state of M.tuberculosis in the tissues of patients with disease are 
handicapped by the absence of comprehensive specimen collections and methodologies 
to differentiate cells states reliably in situ. If we are to understand the effect of these 
dormancy phenotypes on chemotherapy it is necessary to chart the number, occasion 
and cell state of M. tuberculosis  in patients with disease, and to understand the rate that 
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“dormant” cells transition to “active” states.   The challenge for the future is to integrate 
these disparate models and data into a cohesive theory of pathology and its impact on 
the natural history of tuberculosis and the therapy of the disease. Dormancy researchers 
agree that the factors underpinning the phenomenon of dormancy are important, 
complex and nuanced.  If we are to make progress we need to agree and use a consistent 
nomenclature.  To support this approach we have proposed a candiate terminology for 
dormant TB, which should be updated regularly as new data become available.   If we do 
not, progress will continue to stumble through mists of uncertain meaning. 
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Table1.  Summary of mycobacterial dormancy models with a description of methods of selecting cellular sub-types, and the  
phenotypic and metabolic characteristics  
Principle of model and 
organism 
Morphology of 
cells 
Buoyant 
density 
Metabolism Microscopic 
observations 
Viability 
challenges 
Lipids in 
resultant cells 
Gradual acidification, M. 
smegmatis [17,86] 
Three types of 
cells formed: 
ovoid, 
transitional, rod 
shaped – 60% 
ovoid after 30 
days 
Ovoid cells 
higher 
buoyant 
density 1.8M 
zone in 1.4-
2.2 M 
sucrose 
gradient  
Post-stationary 
cultures exhibit 
low but non zero 
uptake of 
radioactive 
DNA/RNA 
precursors no 
detectable 
respiration 
Thickened, 
multi-layered 
cell wall, 
electron dense 
cytoplasm 
Ovoid forms 
more resistant to 
antibiotics and 
heat 
Not reported 
Growth in modified potassium 
free medium, M. smegmatis [87] 
Spherical cells, 
condensation of 
cytoplasm 
 Decreased total 
metabolic activity 
and total 
respiratory 
activity 
Increased 
number 
vacuoles, 
decreased 
ribosomes. Cells 
with “rarefied” 
cytoplasm non-
viable 
 Total amount of 
lipid 2-fold 
lower than 
metabolically 
active cells. 
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Multiple-stress model on 
M.tuberculosis[16,20]  
 Buoyant 
density 
decreased 
with 
increasing 
time under 
multiple 
stress  
-Enzymes of 
glyoxylate cycle 
are up regulated. 
Shutdown of ATP 
and NAD energy 
regeneration 
systems. 
-Overall 
slowdown of 
transcription/ 
translation 
apparatus 
Loss of acid 
fatness – 30% 
after 30 days of 
multiple stress 
Resistance to RIF 
and INH – at 18 
days c. 12% 
survive 5μg/mL 
RIF and c. 35% 
survive 
0.8%μg/mL INH 
Increased lipid 
bodies (70% 
lipid bodies 
positive at 18 
days). 
Accumulation of 
storage lipids 
(WE and TG) in 
anaerobic but 
not aerobic 
samples 
Nutrient starvation 
M.tuberculosis [54] 
  Significantly 
decreased 
respiration rate 
 No loss of 
viability after 6 
weeks. Starved 
cultures resistant 
to RIF and INH at 
1 μgmL-1 
Sensitive to 
metronidazole 
Down-regulation 
of genes 
involved in lipid 
biosynthesis 
(micro-array) 
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Low oxygen tension M. bovis and 
M.tuberculosis [88] 
Cell diameter of 
anaerobically 
cultured cells 
significantly 
thinner than 
aerobic: M. bovis 
255 vs 284 nm. 
M.tb 278 vs 338 
nm 
  M.tuberculosis, 
M. bovis- 
Markedly 
thickened (21.2 
vs 16.1 nm) cell 
wall with 
rupturing and 
pealing after 6 
months in 
anaerobic or 
micro-aerobic 
but not aerobic 
conditions. 
-No thickening in 
M. smegmatis – 
less than 1 % of 
cells intact in 35 
culture days. 
 Not reported 
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Long term anaerobic culture, 
M.tuberculosis [88] 
No difference in 
cell length 
between 
anaerobic and 
aerobic cultures 
(1.14 vs 1.06 
μm) 
  Thickened cell 
wall, dependent 
on anaerobiosis 
and not cell 
density. APP1 
pigment 
produced, only 
significantly in 
anaerobic 
cultures 
 No qualitative 
difference in cell 
wall lipids 
Plate based anaerobiosis M. 
smegmatis [89] 
    Sensitivity to 
MTZ in 
anaerobically 
grown cultures 
Not reported 
Oxygen depletion M. 
smegmatis[90] 
Percentage of 
bacilli survival 
M. smegmatis 
CFU counting 
after 24h 
exposure to the 
drug 
 Low level DNA 
and RNA synthesis 
 Anaerobic 
culture sensitive 
to MTZ but not 
OF  
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
4 
Oxygen shift down 
M.tuberculosis [16] 
  DNA synthesis 
terminates with 
cell division but 
some low level 
RNA synthesis 
continues. Slight 
fall in ATP as cells 
enter stationary 
phase 
 Non-replicating 
persistent cells 
resistant to INH 
and CIP but not 
to MTZ 
Not reported 
Wayne like oxygen depletion 
M.tuberculosis [91] 
  Specific glycine 
dehydrogenase 
activity increases 
sharply in NRP1 
but declines in 
NRP2. Isocitrate 
lyase down-
regulated in 
anaerobic cultures 
 Anaerobic 
cultures develop 
dose dependent 
Metronidazole 
susceptibility 
Nor reported 
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Culture in mHdeBa medium M. 
smegmatis [92] 
Bacteria are 
Clumping and 2 
to 3 times 
smaller  
 Low metabolism 
(rhodamine-123 
staining) and 
negligible 
endogenous 
respiration 
  Not reported 
Human granuloma in vitro 
model M.tuberculosis [93] 
    Significantly 
more cells 
resistant to 
rifampin after 8 
days exposure to 
model 
Loss of acid 
fastness and 
increase in Nile 
Red positive 
staining after 8 
days of exposure 
to model 
 
 
a Hartman’s–de Bont medium  
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Text box1. Assumptions around dormancy 
The critical, implicit and as yet untested assumption is that  
  all dormancy phenotypes are equivalent  
  that the phenotypes are predictive of a state found in the human host.      
  bacteria in specimens and in tissue samples and animal models of disease share some phenotypic characteristics associated with 
dormancy 
  there is no unequivocal marker that identify mycobacterial cells in a dormant state 
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Text box 2  Examples of nomenclature for different dormancy states and the application  of the scheme to describe a cell or 
cells  
  A = Actively dividing cells 
  M = Multiplication rate high, medium, low , undetectable (h,m,l, u) qualified by medium used: 
  Growth medium  S=solid, L=Liquid, A=animals( Mi=mice, R=rats, G=guinea-pigs, S=simian) e.g., MuS 
   Meth,m,l   =Metabolic rate high, medium, low. Addition of method used to detect growth could be: S35=Methionine S35 uptake.  
U=Uridine Tritiated uptake . ATP=ATP production 
  Tol  = Tolerant to antbiotics R=Rif, H=Isoniazid, E=ethambutol , Z=pyrazinamide 
  S      =Sensitive to antibiotics R, H, E, Z 
  Rpf   =  Resuscitation Promoting Factor dependent 
  λ +/-  =Lipid body present (+) or absent(-) 
Thus, a cell or group of cells that was/were unculturable in solid and liquid but grow in mice, are tolerant of rifampicin, and 
resuscitated by the addition of Rpf would be represented by Mu SLMhMiAm, TolR, Rpf.  
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Table 2 Relative susceptibility of mycobacterial species to anti-tuberculosis agents in differing models of “dormancy”.   
 Model Methodologies 
How was 
susceptibility 
measured? 
Susceptibilities 
Isoniazid 
 
Rifampicin 
 
Pyrazinamide 
 
Ciprofloxacin 
 
Metronidazole 
Gradual acidification 
 
TB 
MIC [92,94] 0.05µg/mL 0.5µg/mL 20µg/mL   
Growth in modified 
potassium free 
medium 
MIC [95]Plate 
counting 
methodology 
lowest viable 
number- TB 
1.0µg/mL 5.0 µg/mL    
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Multiple-stress model 
 
TB 
Cell survival after 
≥96h exposure to 
indicated levels 
of drug- CFU 
count [20] 
0.8µg/mL 5.0µg/mL   12µg/mL 
Nutrient starvation 
 
TB 
Cell survival after 
168h exposure to 
indicated levels 
of drug- CFU 
count [54] 
10µg/mL 10µg/mL    
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Low oxygen tension 
 
TB 
MBC90 Wayne 
cidal 
concentration- 
the concentration 
of drug that 
reduced the CFU 
of the initial 
inoculum by 90% 
after 5 days 
exposure [96] 
4.0 µg/mL     
Long term anaerobic 
culture 
TB 
7, 14, 21 day 
exposures to 
drugs – CFU / 
MGIT (non-
growth 
determined after 
negative for 100 
days) [97] 
 8µg/mL 100µg/mL  8µg/mL 
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Plate based 
anaerobiosis 
M.tuberculosis 
number of viable 
cells determined 
by CFU on 7h11 
[98] 
 
M. smegmatis 
Solid media 
plating for CFU 
counting. 
25 uM viable cell 
count is reduced 
by 50% 
compared to the 
control [98]. 
   Wild type viable counts 
are reduced a 100 fold 
at 100 µg/mL.  [89] 
Oxygen depletion BCG 
Solid media 
plating for CFU 
counting.   
[89,91] 
    BCG viable count are 
reduced a 1000 fold at 
100 µg/mL  and 3 fold 
at 10 µg/mL. There is a 
dose dependent effect 
using MTZ. 
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Oxygen shift down 
(Wayne model) 
TB 
M.tuberculosis 
cells survival. 
Solid media 
plating for CFU 
counting. 
0.4µg/mL [16] 0.1µg/mL[16]  1µg/mL[16] 12 µg/mL in “non 
replicating stage 
2”(Wayne & Hayes, 
1996) 
8 µg/mL (Wayne & 
Sramek, 1994) 
Oxygen  depletion 
 
Percentage of 
bacilli survival 
M. smegmatis 
CFU counting 
after 24h 
exposure to the 
drug[90] 
    120 µg/mL 
20 ± 10 percent survival 
for persistent culture 
(240 hours old sealed 
culture). 
95 ± 9 percent survival 
for active culture 
(logarithmic aerobic 
culture).  
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Culture in mHdeBa 
medium  
M. smegmatis 
percentage of 
resazurin (0 
percent resazurin 
reduction)[99] 
 
Mtb h37rv  
MIC90 using 
resazurin 
microplate assay 
(REMA) [99] 
10  µM 1µM 
 
 
 
 
less than 
0.19µM 
MBC90: 
>100µM 
 1µM  
Human granuloma in 
vitro model[93] 
M.tb 
MIC defined 
using Alamar 
blue reduction 
[76] 
MIC: 1.25-2.5 
µg/mL[76] 
MIC: 0.47-0.94 
µg/mL [76] 
 
   
a Hartman’s–de Bont medium  
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Table 3 Summary of publications and their associated definitions of “dormancy”. 
Authors and reference Definition  
(Shleeva, Salina, & Kaprelyants, 
2010)[100] 
The dormant state is understood here 
as a reversible state of a bacterial cell, 
when the level of metabolic activity is 
decreased and the cell is able to survive 
for a long time without division 
(Gengenbacher & Kaufmann, 2012)[53] Non- replicating bacilli maintaining full 
viability at a very low metabolic rate; 
organisms show minor susceptibility or 
phenotypic drug resistance to 
antibiotics targeting functions required 
for growth. 
(Voskuil, Visconti, & Schoolnik, 
2004)[33] 
Without replication or significant 
metabolism. 
(Mariotti et al., 2013)[101] Dormancy is defined as a stable but 
reversible non-replicating state of 
Mycobacterium tuberculosis. 
(Kaprelyants, Gottschal, & Kell, 
1993)[102] 
A reversible state of low metabolic 
activity, in which cells can persist for 
extended periods without division. 
Karakousis et al., 2004) [103] an    Altered physiologic state characterized by 
stationary-state colony-forming unit 
counts and decreased metabolic activity 
and greater susceptibility to rifampin than 
isoniazid. 
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Figure 1.  Mycobacterial cells stained with Nile Red  and viewed by fluorescence 
microscopy at 100X (Leica DM5500) (excitation; 480/40, 540/40. Emission 527/30, 
645/75) showing lipid poor cells (red) and lipid rich cells (red with central green lipid 
body.  This is set alongside a hypothetical mycobacterial growth curve and the change in 
the phenotypic susceptibility over time in a batch culture.   
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Figure 2.  Illustration of how the “Scout” hypothesis might link to concepts of dormancy 
with dormant mycobacterial cells in the tuberculosis lesion “reactivating” and emerging.  
The fate of the lesion would depend on whether the re-activated or resuscitated scout to 
survive and give a signal.      
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
3 
References 
[1] Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, et 
al. Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. 
N Engl J Med 2014;371:1577–87. doi:10.1056/NEJMoa1407426. 
[2] Jindani A, Harrison TS, Nunn AJ, Phillips PPJ, Churchyard GJ, Charalambous S, 
et al. High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N 
Engl J Med 2014;371:1599–608. doi:10.1056/NEJMoa1314210. 
[3] Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T, et al. A four-
month gatifloxacin-containing regimen for treating tuberculosis. N Engl J 
Med 2014;371:1588–98. doi:10.1056/NEJMoa1315817. 
[4] Phillips PPJ, Mendel CM, Burger DA, Crook A, Nunn AJ, Dawson R, et al. 
Limited role of culture conversion for decision-making in individual patient 
care and for advancing novel regimens to confirmatory clinical trials. BMC 
Med 2016;14:19. doi:10.1186/s12916-016-0565-y. 
[5] Prideaux B, Via LE, Zimmerman MD, Eum S, Sarathy J, O'Brien P, et al. The 
association between sterilizing activity and drug distribution into 
tuberculosis lesions. Nat Med 2015. doi:10.1038/nm.3937. 
[6] Bigger J. Treatment of Staphylococcal infections with penicillin by 
intermittent sterilisation. Lancet n.d.;244:497–500. 
[7] Baek S-H, Li AH, Sassetti CM. Metabolic regulation of mycobacterial growth 
and antibiotic sensitivity. PLoS Biol 2011;9:e1001065–5. 
doi:10.1371/journal.pbio.1001065. 
[8] Canetti G. The tubercle bacillus. New York: 1955. 
[9] Mukamolova GV, Turapov O, Malkin J, Woltmann G, Barer MR. Resuscitation-
promoting Factors Reveal an Occult Population of Tubercle Bacilli in 
Sputum. Am J Respir Crit Care Med 2010;181:174–80. 
doi:10.1164/rccm.200905-0661OC. 
[10] Freeman R, Dunn J, Magee J, Barrett A. The enhancement of isolation of 
mycobacteria from a rapid liquid culture system by broth culture supernate 
of Micrococcus luteus. J Med Microbiol 2002;51:92–3. 
[11] Hu Y, Liu A, Ortega-Muro F, Alameda-Martin L, Mitchison D, Coates A. High-
dose rifampicin kills persisters, shortens treatment duration, and reduces 
relapse rate in vitro and in vivo. Front Microbiol 2015;6:641. 
doi:10.3389/fmicb.2015.00641. 
[12] Hu Y, Mangan JA, Dhillon J, Sole KM, Mitchison DA, Butcher PD, et al. 
Detection of mRNA transcripts and active transcription in persistent 
Mycobacterium tuberculosis induced by exposure to rifampin or 
pyrazinamide. J Bacteriol 2000;182:6358–65. 
[13] Manina G, Dhar N, McKinney JD. Stress and host immunity amplify 
Mycobacterium tuberculosis phenotypic heterogeneity and induce 
nongrowing metabolically active forms. Cell Host Microbe 2015;17:32–46. 
doi:10.1016/j.chom.2014.11.016. 
[14] Shleeva M, Kondratieva T, Rubakova E, Vostroknutova G, Kaprelyants A, Apt 
A. Reactivation of dormant “non-culturable” Mycobacterium tuberculosis 
developed in vitro after injection in mice: both the dormancy depth and host 
genetics influence the outcome. Microb Pathog 2015;78:63–6. 
doi:10.1016/j.micpath.2014.11.016. 
[15] Loebel RO, Shorr E, Richardson HB. The Influence of Foodstuffs upon the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
4 
Respiratory Metabolism and Growth of Human Tubercle Bacilli. J Bacteriol 
1933;26:139–66. 
[16] Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of 
Mycobacterium tuberculosis through two stages of nonreplicating 
persistence. Infection and Immunity 1996;64:2062–9. 
[17] Shleeva MO, Kudykina YK, Vostroknutova GN, Suzina NE, Mulyukin AL, 
Kaprelyants AS. Dormant ovoid cells of Mycobacterium tuberculosis are 
formed in response to gradual external acidification. Tuberculosis (Edinb) 
2011;91:146–54. doi:10.1016/j.tube.2010.12.006. 
[18] Keren I, Minami S, Rubin E, Lewis K. Characterization and transcriptome 
analysis of Mycobacterium tuberculosis persisters. mBio 2011;2:e00100–11. 
doi:10.1128/mBio.00100-11. 
[19] Reed MB, Gagneux S, Deriemer K, Small PM, Barry CE. The W-Beijing lineage 
of Mycobacterium tuberculosis overproduces triglycerides and has the DosR 
dormancy regulon constitutively upregulated. J Bacteriol 2007;189:2583–9. 
doi:10.1128/JB.01670-06. 
[20] Deb C, Lee C-M, Dubey VS, Daniel J, abomoelak B, sirakova TD, et al. A Novel 
In Vitro Multiple-Stress Dormancy Model for Mycobacterium tuberculosis 
Generates a Lipid-Loaded, Drug-Tolerant, Dormant Pathogen. PLoS ONE 
n.d.;4:15. doi:10.1371/journal.pone.0006077.t003. 
[21] Park H-D, Guinn KM, Harrell MI, Liao R, Voskuil MI, Tompa M, et al. 
Rv3133c/dosR is a transcription factor that mediates the hypoxic response 
of Mycobacterium tuberculosis. Mol Microbiol 2003;48:833–43. 
[22] Burdon KL. Fatty Material in Bacteria and Fungi Revealed by Staining Dried, 
Fixed Slide Preparations. J Bacteriol 1946;52:665–78. 
[23] Burdon KL. Disparity in Appearance of True Hansen's Bacilli and Cultured 
‘Leprosy Bacilli’ When Stained for Fat. J Bacteriol 1946;52:679–80. 
[24] Garton NJ, Christensen H, Minnikin DE, Adegbola RA, Barer MR. Intracellular 
lipophilic inclusions of mycobacteria in vitro and in sputum. Microbiology 
(Reading, Engl) 2002;148:2951–8. 
[25] Gomez JE, McKinney JD. M. tuberculosis persistence, latency, and drug 
tolerance. Tuberculosis (Edinb) 2004;84:29–44. 
[26] D'Avila H, Melo RCN, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, 
Bozza PT. Mycobacterium bovis bacillus Calmette-Guérin induces TLR2-
mediated formation of lipid bodies: intracellular domains for eicosanoid 
synthesis in vivo. J Immunol 2006;176:3087–97. 
[27] Garton NJ, Waddell SJ, Sherratt AL, Lee S-M, Smith RJ, Senner C, et al. 
Cytological and Transcript Analyses Reveal Fat and Lazy Persister-Like 
Bacilli in Tuberculous Sputum. PLoS Med 2008;5:e75. 
doi:10.1371/journal.pmed.0050075.st006. 
[28] Bowness R, Boeree MJ, Aarnoutse R, Dawson R, Diacon A, Mangu C, et al. The 
relationship between Mycobacterium tuberculosis MGIT time to positivity 
and cfu in sputum samples demonstrates changing bacterial phenotypes 
potentially reflecting the impact of chemotherapy on critical sub-
populations. Journal of Antimicrobial Chemotherapy 2014:dku415. 
doi:10.1093/jac/dku415. 
[29] Sloan DJ, Mwandumba HC, Garton NJ, Khoo SH, Butterworth AE, Allain TJ, et 
al. Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection 
of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
5 
Treatment of Pulmonary Tuberculosis. Clinical Infectious Diseases 
2015:civ195. doi:10.1093/cid/civ195. 
[30] Hammond RJH, Baron VO, Oravcova K, Lipworth S, Gillespie SH. Phenotypic 
resistance in mycobacteria: is it because I am old or fat that I resist you? 
Journal of Antimicrobial Chemotherapy 2015;70:2823–7. 
doi:10.1093/jac/dkv178. 
[31] Hu Y, Coates AR. Transcription of the stationary-phase-associated hspX gene 
of Mycobacterium tuberculosis is inversely related to synthesis of the 16-
kilodalton protein. J Bacteriol 1999;181:1380–7. 
[32] Hu Y, Movahedzadeh F, Stoker NG, Coates ARM. Deletion of the 
Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes 
increased bacterial growth in vivo. Infection and Immunity 2006;74:861–8. 
doi:10.1128/IAI.74.2.861-868.2006. 
[33] Voskuil MI, Visconti KC, Schoolnik GK. Mycobacterium tuberculosis gene 
expression during adaptation to stationary phase and low-oxygen dormancy. 
Tuberculosis (Edinb) 2004;84:218–27. doi:10.1016/j.tube.2004.02.003. 
[34] Kumar A, Toledo JC, Patel RP, Lancaster JR, Steyn AJC. Mycobacterium 
tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc Natl 
Acad Sci USa 2007;104:11568–73. doi:10.1073/pnas.0705054104. 
[35] Schubert OT, Ludwig C, Kogadeeva M, Zimmermann M, Rosenberger G, 
Gengenbacher M, et al. Absolute Proteome Composition and Dynamics 
during Dormancy and Resuscitation of Mycobacterium tuberculosis. Cell 
Host Microbe 2015;18:96–108. doi:10.1016/j.chom.2015.06.001. 
[36] Rustad TR, Harrell MI, Liao R, Sherman DR. The enduring hypoxic response 
of Mycobacterium tuberculosis. PLoS ONE 2008;3:e1502. 
doi:10.1371/journal.pone.0001502. 
[37] Rustad TR, Sherrid AM, Minch KJ, Sherman DR. Hypoxia: a window into 
Mycobacterium tuberculosis latency. Cell Microbiol 2009;11:1151–9. 
doi:10.1111/j.1462-5822.2009.01325.x. 
[38] Mehra S, Foreman TW, Didier PJ, Ahsan MH, Hudock TA, Kissee R, et al. The 
DosR Regulon Modulates Adaptive Immunity and Is Essential for 
Mycobacterium tuberculosis Persistence. Am J Respir Crit Care Med 
2015;191:1185–96. doi:10.1164/rccm.201408-1502OC. 
[39] Minch K, Rustad T, Sherman DR. Mycobacterium tuberculosis growth 
following aerobic expression of the DosR regulon. PLoS ONE 2012;7:e35935. 
doi:10.1371/journal.pone.0035935. 
[40] Orme IM. A new unifying theory of the pathogenesis of tuberculosis. 
Tuberculosis (Edinb) 2014;94:8–14. doi:10.1016/j.tube.2013.07.004. 
[41] Tsai MC, Chakravarty S, Zhu G, Xu J, Tanaka K, Koch C, et al. Characterization 
of the tuberculous granuloma in murine and human lungs: cellular 
composition and relative tissue oxygen tension. Cell Microbiol 2006;8:218–
32. doi:10.1111/j.1462-5822.2005.00612.x. 
[42] Dhillon J, Allen BW, Hu YM, Coates AR, Mitchison DA. Metronidazole has no 
antibacterial effect in Cornell model murine tuberculosis. Int J Tuberc Lung 
Dis 1998;2:736–42. 
[43] Wayne LG, Sramek HA. Metronidazole is bactericidal to dormant cells of 
Mycobacterium tuberculosis. Antimicrob Agents Chemother 1994;38:2054–
8. 
[44] Garhyan J, Bhuyan S, Pulu I, Kalita D, Das B, Bhatnagar R. Preclinical and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
6 
Clinical Evidence of Mycobacterium tuberculosis Persistence in the Hypoxic 
Niche of Bone Marrow Mesenchymal Stem Cells after Therapy. Am J Pathol 
2015;185:1924–34. doi:10.1016/j.ajpath.2015.03.028. 
[45] Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, Eum SY, et al. Tuberculous 
granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. 
Infection and Immunity 2008;76:2333–40. doi:10.1128/IAI.01515-07. 
[46] Aly S, Wagner K, Keller C, Malm S, Malzan A, Brandau S, et al. Oxygen status 
of lung granulomas in Mycobacterium tuberculosis-infected mice. J Pathol 
2006;210:298–305. doi:10.1002/path.2055. 
[47] Klinkenberg LG, Sutherland LA, Bishai WR, Karakousis PC. Metronidazole 
lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic 
granuloma model of latency. J Infect Dis 2008;198:275–83. 
doi:10.1086/589515. 
[48] Hoff DR, Caraway ML, Brooks EJ, Driver ER, Ryan GJ, Peloquin CA, et al. 
Metronidazole lacks antibacterial activity in guinea pigs infected with 
Mycobacterium tuberculosis. Antimicrob Agents Chemother 2008;52:4137–
40. doi:10.1128/AAC.00196-08. 
[49] Converse PJ, Karakousis PC, Klinkenberg LG, Kesavan AK, Ly LH, Allen SS, et 
al. Role of the dosR-dosS two-component regulatory system in 
Mycobacterium tuberculosis virulence in three animal models. Infection and 
Immunity 2009;77:1230–7. doi:10.1128/IAI.01117-08. 
[50] Lenaerts AJ, Hoff D, Aly S, Ehlers S, Andries K, Cantarero L, et al. Location of 
persisting mycobacteria in a Guinea pig model of tuberculosis revealed by 
r207910. Antimicrob Agents Chemother 2007;51:3338–45. 
doi:10.1128/AAC.00276-07. 
[51] SEVER JL, Youmans GP. The relation of oxygen tension to virulence of 
tubercle bacilli and to acquired resistance in tuberculosis. J Infect Dis 
1957;101:193–202. 
[52] Loebel RO, Shorr E, Richardson HB. The Influence of Adverse Conditions 
upon the Respiratory Metabolism and Growth of Human Tubercle Bacilli. J 
Bacteriol 1933;26:167–200. 
[53] Gengenbacher M, Kaufmann SHE. Mycobacterium tuberculosis: success 
through dormancy. FEMS Microbiology Reviews 2012;36:514–32. 
doi:10.1111/j.1574-6976.2012.00331.x. 
[54] Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient 
starvation model of Mycobacterium tuberculosis persistence by gene and 
protein expression profiling. Mol Microbiol 2002;43:717–31. 
[55] Betts JC, Dodson P, Quan S, Lewis AP, Thomas PJ, Duncan K, et al. 
Comparison of the proteome of Mycobacterium tuberculosis strain H37Rv 
with clinical isolate CDC 1551. Microbiology (Reading, Engl) 2000;146 Pt 
12:3205–16. 
[56] Hampshire T, Soneji S, Bacon J, James BW, Hinds J, Laing K, et al. Stationary 
phase gene expression of Mycobacterium tuberculosis following a 
progressive nutrient depletion: a model for persistent organisms? 
Tuberculosis (Edinb) 2004;84:228–38. doi:10.1016/j.tube.2003.12.010. 
[57] Xie Z, Siddiqi N, Rubin EJ. Differential antibiotic susceptibilities of starved 
Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 
2005;49:4778–80. doi:10.1128/AAC.49.11.4778-4780.2005. 
[58] Anuchin AM, Mulyukin AL, Suzina NE, Duda VI, El-Registan GI, Kaprelyants 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
7 
AS. Dormant forms of Mycobacterium smegmatis with distinct morphology. 
Microbiology 2009;155:1071–9. doi:10.1099/mic.0.023028-0. 
[59] Rifat D, Bishai WR, Karakousis PC. Phosphate depletion: a novel trigger for 
Mycobacterium tuberculosis persistence. J Infect Dis 2009;200:1126–35. 
doi:10.1086/605700. 
[60] Rengarajan J, Bloom BR, Rubin EJ. Genome-wide requirements for 
Mycobacterium tuberculosis adaptation and survival in macrophages. Proc 
Natl Acad Sci USa 2005;102:8327–32. doi:10.1073/pnas.0503272102. 
[61] Rohde KH, Veiga DFT, Caldwell S, Balázsi G, Russell DG. Linking the 
transcriptional profiles and the physiological states of Mycobacterium 
tuberculosis during an extended intracellular infection. PLoS Pathog 
2012;8:e1002769. doi:10.1371/journal.ppat.1002769. 
[62] Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979;76:771–81. 
[63] Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and 
bacillus that contribute to persistent infection. The Lancet Infectious 
Diseases 2003;3:578–90. 
[64] Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance 
to antimicrobials. FEMS Microbiology Letters 2004;230:13–8. 
[65] Dahl JL, Kraus CN, Boshoff HIM, Doan B, Foley K, Avarbock D, et al. The role 
of RelMtb-mediated adaptation to stationary phase in long-term persistence 
of Mycobacterium tuberculosis in mice. Proc Natl Acad Sci USa 
2003;100:10026–31. doi:10.1073/pnas.1631248100. 
[66] Klinkenberg LG, Lee J-H, Bishai WR, Karakousis PC. The stringent response is 
required for full virulence of Mycobacterium tuberculosis in guinea pigs. J 
Infect Dis 2010;202:1397–404. doi:10.1086/656524. 
[67] Thayil SM, Morrison N, Schechter N, Rubin H, Karakousis PC. The role of the 
novel exopolyphosphatase MT0516 in Mycobacterium tuberculosis drug 
tolerance and persistence. PLoS ONE 2011;6:e28076. 
doi:10.1371/journal.pone.0028076. 
[68] Mukamolova GV, Kaprelyants AS, Young DI, Young M, Kell DB. A bacterial 
cytokine. Proc Natl Acad Sci USa 1998;95:8916–21. 
[69] Hu Y, Coates ARM, Mitchison DA. Comparison of the sterilising activities of 
the nitroimidazopyran PA-824 and moxifloxacin against persisting 
Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2008;12:69–73. 
[70] Hu Y, Coates AR, Mitchison DA. Sterilising action of pyrazinamide in models 
of dormant and rifampicin-tolerant Mycobacterium tuberculosis. Int J 
Tuberc Lung Dis 2006;10:317–22. 
[71] Hu Y, Coates ARM, Mitchison DA. Sterilizing activities of fluoroquinolones 
against rifampin-tolerant populations of Mycobacterium tuberculosis. 
Antimicrob Agents Chemother 2003;47:653–7. doi:10.1128/AAC.47.2.653-
657.2003. 
[72] Fox W, Sutherland I, Daniels M. A five-year assessment of patients in a 
controlled trial of streptomycin in pulmonary tuberculosis; report to the 
Tuberculosis Chemotherapy Trials Committee of the Medical Research 
Council. Q J Med 1954;23:347–66. 
[73] Mccune Rm, Feldmann Fm, Lambert Hp, Mcdermott W. Microbial 
persistence. I. The capacity of tubercle bacilli to survive sterilization in 
mouse tissues. J Exp Med 1966;123:445–68. 
[74] Mccune RM, Feldmann FM, Mcdermott W. Microbial Persistence. Ii. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
8 
Characteristics of the sterile state of tubercle bacilli. J Exp Med 
1966;123:469–86. 
[75] Scanga CA, Mohan VP, Joseph H, Yu K, Chan J, Flynn JL. Reactivation of latent 
tuberculosis: variations on the Cornell murine model. Infection and 
Immunity 1999;67:4531–8. 
[76] Ackart DF, Hascall-Dove L, Caceres SM, Kirk NM, Podell BK, Melander C, et al. 
Expression of antimicrobial drug tolerance by attached communities of 
Mycobacterium tuberculosis. Pathogens and Disease 2014;70:359–69. 
doi:10.1111/2049-632X.12144. 
[77] Zhang Y, Yew WW, Barer MR. Targeting persisters for tuberculosis control. 
Antimicrob Agents Chemother 2012;56:2223–30. doi:10.1128/AAC.06288-
11. 
[78] Shleeva MO, Bagramyan K, Telkov MV, Mukamolova GV, Young M, Kell DB, et 
al. Formation and resuscitation of “non-culturable” cells of Rhodococcus 
rhodochrous and Mycobacterium tuberculosis in prolonged stationary 
phase. Microbiology (Reading, Engl) 2002;148:1581–91. 
[79] Epstein SS. Microbial awakenings. Nature 2009;457:1083. 
doi:10.1038/4571083a. 
[80] Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, et al. The spectrum of 
latent tuberculosis: rethinking the biology and intervention strategies. Nat 
Rev Microbiol 2009;7:845–55. doi:10.1038/nrmicro2236. 
[81] Harries AD, Dye C. Tuberculosis. Ann Trop Med Parasitol 2006;100:415–31. 
doi:10.1179/136485906X91477. 
[82] Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-γ release 
assays and tuberculin skin testing for progression from latent TB infection to 
disease state: a meta-analysis. Chest 2012;142:63–75. doi:10.1378/chest.11-
3157. 
[83] Neyrolles O, Hernández-Pando R, Pietri-Rouxel F, Fornès P, Tailleux L, 
Barrios Payán JA, et al. Is adipose tissue a place for Mycobacterium 
tuberculosis persistence? PLoS ONE 2006;1:e43. 
doi:10.1371/journal.pone.0000043. 
[84] Hernandez-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe 
M, et al. Persistence of DNA from Mycobacterium tuberculosis in 
superficially normal lung tissue during latent infection. Lancet 
2000;356:2133–8. 
[85] Barrios-Payán J, Saqui-Salces M, Jeyanathan M, Alcántara-Vazquez A, 
Castañon-Arreola M, Rook G, et al. Extrapulmonary locations of 
mycobacterium tuberculosis DNA during latent infection. J Infect Dis 
2012;206:1194–205. doi:10.1093/infdis/jis381. 
[86] Kudykina YK, Shleeva MO, Artsabanov VY, Suzina NE, Kaprel'iants AS. 
[Generation of dormant forms by Mycobacterium smegmatis in the 
poststationary phase during gradual acidification of the medium]. 
Mikrobiologiia 2011;80:625–36. 
[87] Salina EG, Zhogina YA, Shleeva MO, Sorokoumova GM, Selishcheva AA, 
Kaprelyants AS. Biochemical and morphological changes in dormant 
(“Nonculturable”) Mycobacterium smegmatis cells. Biochemistry Mosc 
2010;75:72–80. 
[88] Cunningham AF, Ashton PR, Spreadbury CL, Lammas DA, Craddock R, 
Wharton CW, et al. Tubercle bacilli generate a novel cell wall-associated 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
9 
pigment after long-term anaerobic culture. FEMS Microbiology Letters 
2004;235:191–8. doi:10.1016/j.femsle.2004.04.036. 
[89] Lim A, Dick T. Plate-based dormancy culture system for Mycobacterium 
smegmatis and isolation of metronidazole-resistant mutants. FEMS 
Microbiology Letters 2001;200:215–9. 
[90] Dick T, Lee BH, Murugasu-Oei B. Oxygen depletion induced dormancy in 
Mycobacterium smegmatis. FEMS Microbiology Letters 1998;163:159–64. 
[91] Lim A, Eleuterio M, Hutter B, Murugasu-Oei B, Dick T. Oxygen depletion-
induced dormancy in Mycobacterium bovis BCG. J Bacteriol 1999;181:2252–
6. 
[92] Shleeva M, Mukamolova GV, Young M, Williams HD, Kaprelyants AS. 
Formation of “non-culturable” cells of Mycobacterium smegmatis in 
stationary phase in response to growth under suboptimal conditions and 
their Rpf-mediated resuscitation. Microbiology (Reading, Engl) 
2004;150:1687–97. doi:10.1099/mic.0.26893-0. 
[93] Kapoor N, Pawar S, sirakova TD, Deb C, Warren WL, Kolattukudy PE. Human 
granuloma in vitro model, for TB dormancy and resuscitation. PLoS ONE 
2013;8:e53657. doi:10.1371/journal.pone.0053657. 
[94] Wayne LG, Lin KY. Glyoxylate metabolism and adaptation of Mycobacterium 
tuberculosis to survival under anaerobic conditions. Infection and Immunity 
1982;37:1042–9. 
[95] Salina EG, Waddell SJ, Hoffmann N, Rosenkrands I, Butcher PD, Kaprelyants 
AS. Potassium availability triggers Mycobacterium tuberculosis transition to, 
and resuscitation from, non-culturable (dormant) states. Open Biol 
2014;4:140106. doi:10.1098/rsob.140106. 
[96] Daniel J, Deb C, Dubey VS, sirakova TD, abomoelak B, Morbidoni HR, et al. 
Induction of a novel class of diacylglycerol acyltransferases and 
triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a 
dormancy-like state in culture. J Bacteriol 2004;186:5017–30. 
doi:10.1128/JB.186.15.5017-5030.2004. 
[97] Filippini P, Iona E, Piccaro G, Peyron P, Neyrolles O, Fattorini L. Activity of 
drug combinations against dormant Mycobacterium tuberculosis. 
Antimicrob Agents Chemother 2010;54:2712–5. doi:10.1128/AAC.01736-
09. 
[98] Mak PA, Rao SPS, Ping Tan M, Lin X, Chyba J, Tay J, et al. A high-throughput 
screen to identify inhibitors of ATP homeostasis in non-replicating 
Mycobacterium tuberculosis. ACS Chem Biol 2012;7:1190–7. 
doi:10.1021/cb2004884. 
[99] Bassett IM, Lun S, Bishai WR, Guo H, Kirman JR, Altaf M, et al. Detection of 
inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using 
an in vitro bactericidal screen. J Microbiol 2013;51:651–8. 
doi:10.1007/s12275-013-3099-4. 
[100] Shleeva MO, Salina EG, Kaprelyants AS. Dormant forms of mycobacteria. 
Microbiology 2010;79:1–12. doi:10.1134/S0026261710010017. 
[101] Mariotti S, Pardini M, Gagliardi MC, Teloni R, Giannoni F, Fraziano M, et al. 
Dormant Mycobacterium tuberculosis Fails To Block Phagosome Maturation 
and Shows Unexpected Capacity To Stimulate Specific Human T 
Lymphocytes. J Immunol 2013;191:274–82. 
doi:10.4049/jimmunol.1202900. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
10 
[102] Kaprelyants AS, Gottschal JC, Kell DB. Dormancy in non-sporulating bacteria. 
FEMS Microbiology Reviews 1993;10:271–85 doi.org/10.1111/j.1574-
6968.1993.tb05871.x. 
 
[103] Karakousis PC, Yoshimatsu T, Lamichhane G, Woolwine SC, Nuermberger EL, 
Grosset J,Bishae WR.  Dormancy Phenotype Displayed by Extracellular 
Mycobacterium tuberculosis within Artificial Granulmoas in MiiceJ Exp Med 
2004;200:647-57. doi:10.1084/jem.20040646. 
  
 
 
 
  
